AzTrials
AzTrials

StrokeNCT02855424

The Effect of Leg Cycling Exercise Program at Low or Moderate Intensity for Individuals With Subacute Stroke

A study testing the low-intensity exercise group and the moderate-intensity exercise group in people with Stroke, run by Kaohsiung Medical University Chung-Ho Memorial Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Poor cardiopulmonary endurance is observed in individuals with acute stroke, even in chronic. In addition, the poor fitness may obstacle activities of daily life, decrease activities of autonomic system, and increase risks of recurrent, therefore, the cardiopulmonary endurance training should be included into the… Read more about this study

Who is it for?
Ages 40 to 80 years
Conditions the study is for
Stroke
What is being tested?
the low-intensity exercise group and the moderate-intensity exercise group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
No sites listed yet
Study dates
Aug 2016to Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • the first-ever stroke
  • period of ischemic stroke onset is longer than two weeks, and less than six months, and the doctors agree with exercise training
  • unilateral hemiplegia
  • no obvious deficits of cognition. Scores of three items in the National Institutes of Health Stroke Scale are zero
  • be willing to join this study and give their consent

Who cannot join

  • aphasia
  • orthopedic problems (severe arthritis), neurologic injury (eg. peripheral nerve injury) that can interfere with movement of the lower limb, or cannot sit independently
  • with pace maker, severe cardiac arrhythmia, or heart failure
  • abnormal electrocardiography in rest, is not suitable for exercise tolerance test according to the American College of Sports Medicine guidance, for example, the atrioventricular block (AV block).

Trial locations and contacts

No sites are listed yet.

About this study

Poor cardiopulmonary endurance is observed in individuals with acute stroke, even in chronic. In addition, the poor fitness may obstacle activities of daily life, decrease activities of autonomic system, and increase risks of recurrent, therefore, the cardiopulmonary endurance training should be included into the early-stage rehabilitation program. The ergocycling training could improve cardiopulmonary endurance for individuals with stroke. Moreover, the low-intensity exercise training can increase the willingness, and it is safer than the moderate-intensity exercise training. However, it needs to be evaluated whether the low-intensity exercise training can bring sufficient benefits, compared to the moderate-intensity exercise training. Objectives of the study is to compare the exercise benefits between the low-intensity and moderate-intensity exercise training, and then these would offer optimal exercise prescription and considerations in clinical practice.

Read the detailed description

After giving their signed consent, subjects would be randomly assigned into the control group (traditional rehabilitation), the low-intensity exercise group (traditional rehabilitation plus low-intensity exercise training), or the moderate-intensity exercise group (traditional rehabilitation plus the moderate-intensity exercise training). Frequency of the exercise training is 2-6 times/week, totally 20 times. In the symptom-limit exercise tolerance tests, subjects wear a gas-collecting mask and electrocardiogram, and pre-set graduated loading was offered by the bike. One therapists and one doctor would monitor the test. For resistance and time setting within each exercise training, it is customized by results of exercise tolerance tests in baseline and the allocation. Moreover, a therapist would stay with subject ,monitor the training, and measure the blood pressure before and after the training.

Conditions
Stroke
Being tested
the low-intensity exercise group, the moderate-intensity exercise group
Keywords
stroke, exercise capacity
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • the low-intensity exercise groupOther

    Totally 20-time training, frequency 2-6 time/week, total 20 times.

  • the moderate-intensity exercise groupOther

    Totally 20-time training, frequency 2-6 time/week,total 20 times.

Study groups in NCT02855424
Study groupRoleWhat they receive
controlNo interventiontraditional rehabilitation merely, no ergocycling training
the low-intensity exercise groupExperimentaltraditional rehabilitation plus the low-intensity ergocycling exercise training
Receives: Other: the low-intensity exercise group
the moderate-intensity exercise groupExperimentaltraditional rehabilitation plus the moderate-intensity ergocycling exercise training
Receives: Other: the moderate-intensity exercise group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. changed value of symptom-limit exercise tolerance tests

    One doctor and one therapist monitor the test. EKG and self-report are used.

    Measured: Baseline, 4 weeks to 10 weeks for exercise completion, one-month follow-up

Secondary outcomes (7)
  1. changed activity of autonomic nervous system (ANS)

    The frequency domain analysis (measure unit of activity of ANS) is used in two conditions (sit and calculate math; 5 minutes/each condition).

    Measured: Baseline, 4 weeks to 10 weeks for exercise completion, one-month follow-up

  2. 10-meter walking test

    Time of performing the 10 meters is measured.

    Measured: Baseline, 4 weeks to 10 weeks for exercise completion, one-month follow-up

  3. changed score of the Barthel index

    Using Barthel index questionnaire

    Measured: Baseline, 4 weeks to 10 weeks for exercise completion, one-month follow-up

  4. changed score of the Stroke-Specific Quality of Life Scale (SSQOL)

    Using SSQOL questionnaire

    Measured: Baseline, 4 weeks to 10 weeks for exercise completion, one-month follow-up

  5. changed value of the Fugl-Meyer Assessment Lower Extremity (FMA-LE)

    Measure items of FMA-LE

    Measured: Baseline, 4 weeks to 10 weeks for exercise completion, one-month follow-up

  6. changed score of Multi-dimensional Fatigue Inventory

    Using Multi-dimensional Fatigue Inventory questionnaire

    Measured: Baseline, 4 weeks to 10 weeks for exercise completion, one-month follow-up

  7. performance of cycling

    the maximal power is recorded by a chip of the training bike continually during each training;2-6 times/week, total 20 times training.

    Measured: 4 weeks to 10 weeks for exercise completion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Aug 2016 (estimated)
  2. Study startAug 2016
  3. Primary completionDec 2019 (estimated)
  4. Study completionDec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02855424
Sponsor's protocol ID
KUMHIRB-F(II)-2016002
Status last verified
Jun 2016
First submitted
6 Jul 2016
Last updated
5 Aug 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing the low-intensity exercise group and the moderate-intensity exercise group in people with Stroke, run by Kaohsiung Medical University Chung-Ho Memorial Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Aug 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Miao-Ju Hsu, PHD (886-7-3121101 ext. 2673, mjhsu@kmu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

changed value of symptom-limit exercise tolerance tests (time frame: Baseline, 4 weeks to 10 weeks for exercise completion, one-month follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT02855424 | AzTrials